New FDA Approval: Ingrezza DrugValbenazine [Ingrezza]IndicationThe treatment of adults with tardive dyskinesia. Read More Clinical, FDA Approval, Pharmacy School, PracticeBrandon DysonMay 5, 2017valbenazine, ingrezza, ingrezza cost, valbenazine cost, tardive dyskinesia, antipsychotic, first generation antipsychotic, second generation antipsychotic, vmat2 inhibitor, fda approval
